SBC Medical Group Holdings (SBC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
28 May, 2026Executive summary
Annual meeting scheduled for July 9, 2026 (JST) / July 8, 2026 (ET), with virtual participation available.
Shareholders are encouraged to review proxy materials and vote by July 7, 2026.
Voting matters and shareholder proposals
Election of four directors: Yoshiyuki Aikawa, Yuya Yoshida, Ken Edahiro, and Fumitoshi Fujiwara.
Ratification of MaloneBailey, LLP as independent auditor for fiscal year ending December 31, 2026.
Proposal to amend the certificate of incorporation to eliminate plurality voting for directors.
Proposal to allow director removal without cause.
Proposal to opt out of Section 203 of Delaware General Corporation Law.
Proposal to provide for officer exculpation.
Proposal for other technical amendments to the certificate of incorporation.
Board of directors and corporate governance
Board recommends approval of all director nominees and proposed amendments.
Proposed governance changes aim to modernize director election and removal processes.
Latest events from SBC Medical Group Holdings
- Shareholders will vote on director elections, auditor ratification, and major charter amendments.SBC
Proxy filing28 May 2026 - Shareholders will vote on director elections, auditor ratification, and major charter amendments.SBC
Proxy filing15 May 2026 - Q1 2026 revenue and net income declined, but underlying growth and liquidity remained strong.SBC
Q1 202614 May 2026 - Net income and EPS rose in 2025 despite revenue declines, with growth expected in 2026.SBC
Q4 20257 Apr 2026 - Scalable multi-brand medical group achieves rapid global growth and high customer retention.SBC
Corporate presentation27 Mar 2026 - Global expansion and financial recovery set the stage for 20%+ international revenue growth.SBC
Emerging Growth Conference 8922 Jan 2026 - Recovery in Japan and global expansion via OrangeTwist partnership drive future growth.SBC
Sidoti Micro-Cap Virtual Investor Conference22 Jan 2026 - Franchise-based cosmetic clinic operator registers $50M equity and 99M shares for resale; CEO retains control.SBC
Registration Filing29 Dec 2025 - Revenue and net income up, with franchise and global growth offsetting Q4 decline.SBC
Q4 202426 Dec 2025